SCHEMBL4254797

SCHEMBL4254797

COc1cccc(Oc2ccc(C(=O)O)cn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
ALDH1A1 P00352 1/20 0.61
BRCA1 P38398 1/20 0.61
HBB P68871 1/20 0.61
HSD17B10 Q99714 1/20 0.61
MAPT P10636 2/20 0.51
GCK P35557 1/20 0.50
MRGPRX4 Q96LA9 1/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.50
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4253237 0.87 MEN1 (0.59) KDM4EMEN1KMT2AALDH1A1BRCA1
SCHEMBL5529678 0.87 KDM4E (0.63) KDM4EMEN1KMT2AALDH1A1BRCA1
SCHEMBL30803809 0.86 MAPT (0.51) KDM4EMEN1KMT2AALDH1A1BRCA1
SCHEMBL30737233 0.85 MAPT (0.49) KDM4EMEN1KMT2AALDH1A1BRCA1
SCHEMBL1271501 0.83 MAPT (0.57) MAPTL3MBTL1HRH3
SCHEMBL693688 0.83 HRH3 (0.60) MAPTGCKMRGPRX4PTGER4HRH3
SCHEMBL4256656 0.83 HRH3 (0.55) KMT2AMAPTGCKGAAL3MBTL1
SCHEMBL30803810 0.83 HRH3 (0.55) KMT2AMAPTGCKGAAL3MBTL1
SCHEMBL30803814 0.83 HRH3 (0.60) MAPTGCKMRGPRX4PTGER4HRH3
SCHEMBL4257593 0.83 PDE4B (0.56) KDM4EMEN1KMT2AALDH1A1BRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885MEN1 4409/4885KMT2A 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.